L-Carnitine 500 mg

L-Carnitine 500 mg

Swanson Premium Brand4.7 (14,372 ratings)
Format:Tablet Quantity: 30 Tablet(s) · 30 servings
Goals
$5.69 $0.18 per serving

Product analysis

62 out of 100

L-Carnitine 500 mg offers an economical way to take L-carnitine, with a possible role in how the body handles blood fats. Its relevance to heart health is narrow, so it may not suit someone seeking broader cardiovascular support.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The L-carnitine form is not identified. That limits a useful comparison of ingredient quality.

Ingredient Transparency63

The L-carnitine amount is stated, making dose comparisons easier. Its form is not identified, leaving that part of the comparison unclear.

Value For Money100

The cost is low for the L-carnitine provided. It offers an economical way to buy this ingredient, without establishing broader heart benefits.

Customer Satisfaction91

Customer ratings are very positive. A large review pool provides a substantial picture of satisfaction, without demonstrating effectiveness.

Product Focus63

The formula has a clear focus on L-carnitine. Its possible relevance to blood fats covers only a narrow part of cardiovascular support.

Format
Tablet
Container
30 Tablet(s)
Per serving
$0.18
Customer rating
4.7 · 14,372 ratings
Report analysis

Goals

Cardiovascular Support
Impact
Moderate effect
B+ Ingredient FitF PathwaysC EvidenceA+ Formulation Logic
L-Carnitine · 500 mg
Study evidence

Ingredients

IngredientAmount per servingScore
L-Carnitine base
500 mg 76
Adults 18–50
Report overview
L-Carnitine · 500 mg OverallScore76
C Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyA+ Value
The serving provides 500 mg active L-carnitine at a low cost per gram. The form is L-carnitine base. A linked source-compound yield is not stated.
How this ingredient is rated

Active Ingredient Quality & Bioavailability63

The form is L-carnitine base. No branded carnitine source or purity standard is named in the available information.
Chemical Form and Goal Alignment
The form is L-carnitine base.
Branded Material and Purity Standards
No branded carnitine source or purity standard is named in the available information.

Dose, Safety & Label Transparency78

The serving lists 500 mg of active L-carnitine. A linked source-compound yield is not stated.
Elemental L-Carnitine Dosage
The serving lists 500 mg of active L-carnitine.
Elemental Yield Disclosure
The active amount is stated, but a linked source-compound amount is not available.

Value100

The cost per gram of active L-carnitine is low.
Price per Gram of Elemental L-Carnitine
The cost per gram of active L-carnitine is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
    Malaguarnera M; Vacante M; Avitabile T; Malaguarnera M; Cammalleri L; Motta M · The American journal of clinical nutrition · 2009
    Randomized trial81 participantsCardiovascular Support forL-Carnitine
  2. L-Carnitine's Effect on the Biomarkers of Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Choi M; Park S; Lee M · Nutrients · 2021
    Meta-analysis9 studies pooledCardiovascular Support forL-Carnitine
  3. The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.
    Mirrafiei A; Jayedi A; Shab-Bidar S · Clinical therapeutics · 2024
    Meta-analysis2,041 participants21 studies pooledCardiovascular Support forL-Carnitine
  4. The Effects of L-Carnitine on Echocardiographic Changes in Patients With β-Thalassemia Major and Intermedia.
    Shahidi M; Hashemi SR; Fattahi N; Roshani D; Vahedi S; Sharifi P; Moradveisi B · Journal of pediatric hematology/oncology · 2020
    Randomized trial60 participantsCardiovascular Support forL-Carnitine
  5. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F · Atherosclerosis · 2007
    Randomized trial52 participantsCardiovascular Support forL-Carnitine